P719: RANDOMIZED PHASE 1-2 STUDY TO ASSESS SAFETY AND EFFICACY OF LOW-DOSE (LD) ORAL DECITABINE/CEDAZURIDINE (ASTX727) IN LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS) PATIENTS: INTERIM SAFETY ANALYSIS

Detalles Bibliográficos
Autores principales: Garcia-Manero, Guillermo, Bachishvili, Kimo, A. Griffiths, Elizabeth, M. Zeidan, Amer, Traer, Elie, Saini, Lalit, Amin, Harshad, Mohan, Sanjay, Lübbert, Michael, Maness-Harris, Lori, M Foran, James, Selleslag, Dominik, Xicoy Cirici, Blanca, Aaron Pollyea, Daniel, Sallman, David, Al-Kali, Aref, Berdeja, Jesus, Kathrin Al-Ali, Haifa, Y Zhu, Nancy, Font Lopez, Patricia, Sanz Santillana, Guillermo, Santini, Valeria, A. Yimer, Habte, D Cripe, Larry, Priego, Victor, Odenike, Olatoyosi, Heyrman, Bert, Valcarcel, David, Vachhani, Pankit, Sano, Yuri, Mirakhur, Beloo, Oganesian, Aram, Keer, Harold, Yacoub, Abdulraheem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428680/
http://dx.doi.org/10.1097/01.HS9.0000969780.55126.5b
Descripción
Sumario:

Ejemplares similares